• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cynata Therapeutics Ltd

+ Add to Watchlist

51S:GR

0.206 EUR 0.0000.00%

As of 02:08:03 ET on 11/27/2014.

Snapshot for Cynata Therapeutics Ltd (51S)

Open: - Day's Range: - Volume: 0
Previous Close: 0.206 52wk Range: 0.163 - 0.345 1-Yr Rtn: -35.83%

Stock Chart for 51S

No chart data available.
  • 51S:GR 0.206
  • 1M
  • 1Y
0.206
Interactive 51S Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 51S

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. DAX -
Earnings Per Share (AUD) (ttm) -
Est. EPS (AUD) (06/2015) -0.0370
Est. PEG Ratio -
Market Cap (M EUR) 11.42
Shares Outstanding (M) 55.45
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 51S

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for 51S

Cynata Therapeutics Ltd is involved in regenerative medicine. The Company is focused on the commercialization of a stem cell platform.

Stewart James WasherChairmanRoss Alexander MacdonaldCEO/Managing Director
Kilian KellyVP:Product DevelopmentPeter Gordon WebseSecretary
More Company Profile & Key Executives for 51S

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil